Nifekalant hydrochloride

DRUG2 trials

Sponsors

Sichuan Baili Pharmaceutical Co., Ltd.

Conditions

Ventricular FibrillationVentricular Tachycardia

Phase 4

Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.

Sichuan Baili Pharmaceutical Co., Ltd.Ventricular Fibrillation, Ventricular Tachycardia

Start: 2019-01-15End: 2020-01-30Target: 756Updated: 2019-02-27

Unknown Phase

Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection

Sichuan Baili Pharmaceutical Co., Ltd.Ventricular Fibrillation, Ventricular Tachycardia

Start: 2019-02-18End: 2019-12-30Target: 2000Updated: 2019-03-14